PHARMA: PUTS BIG SERIES B, EXPERIENCED TEAM INTO FIGHT
Amplyx Takes Aim At Antifungals
Originally published November 25, 2015 at 10:30 a.m., updated November 25, 2015 at 10:30 a.m.
San Diego — Biotech investors seeking big returns don’t usually gravitate toward drugs that treat fungal infections...
Take 1 minute to subscribe and you'll get this story immediately, plus:
Already a subscriber? Sign in
- 52 weekly issues
- Subscriber-only digital content every business day, plus full access to SDBJ.com archives
- Book of Lists — the most comprehensive business resource in San Diego
- San Diego 500 — influential business leaders you need to know